scispace - formally typeset
P

Philip C. Calder

Researcher at University of Southampton

Publications -  808
Citations -  70822

Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

Maternal plasma phosphatidylcholine fatty acids and atopy and wheeze in the offspring at age of 6 years.

TL;DR: In this article, the authors investigated whether differences in PUFA concentrations in maternal plasma are associated with the risk of childhood wheeze or atopy, and found that a higher ratio of linoleic acid to its unsaturated metabolic products was associated with reduced risk of skin sensitisation.
Journal ArticleDOI

Dietary lipids and vascular function: UK Food Standards Agency workshop report

TL;DR: The UK Food Standards Agency convened a group of expert scientists to review current research investigating the effect of dietary lipids on vascular function and suggested a beneficial effect of long-chain n-3 PUFA and a detrimental effect of trans fatty acids.
Journal ArticleDOI

Propionate regulates lymphocyte proliferation and metabolism.

TL;DR: The results suggest that inhibition of lipid synthesis is a possible mechanism leading to reduction of lymphocytes proliferation.
Journal ArticleDOI

Effect of a 6-week "Mediterranean" dietary intervention on in vitro human embryo development: the Preconception Dietary Supplements in Assisted Reproduction double-blinded randomized controlled trial.

TL;DR: This study demonstrates that a short period of dietary supplementation alters the rate of embryo cleavage, and further research is required to investigate the mechanisms that regulate this effect, and whether the impact on embryo development translates into improved clinical outcomes.